SWOG 0941: A phase II study of sorafenib and erlotinib in patients (pts) with advanced gallbladder cancer or cholangiocarcinoma. This is an ASCO Meeting Abstract from the 2012 ASCO Annual Meeting I.
The 2026 SNMMI annual meeting featured a genitourinary radiotherapeutics session and a presentation by Dr. Yalda Nikanpour ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results